These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10340125)

  • 1. [The joint use of prednisolone and phospholipid-containing hepatoprotectors in experimental chronic hepatitis].
    Vengerovskiĭ AI; Golovina EL; Kovalenko MIu; Chuchalin VS; Saprykina EV; Sosnina NV; Burkova VN; Saratikov AS
    Eksp Klin Farmakol; 1999; 62(2):28-30. PubMed ID: 10340125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of eplir on an experimental toxic lesion of the liver].
    Saratikov AS; Vengerovskiĭ AI; Paul's OV; Sedykh IM
    Farmakol Toksikol; 1990; 53(5):42-5. PubMed ID: 2253748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatoprotectors containing phospholipids decrease the immunosuppressive effect of prednisolone in rats with experimental toxic hepatitis].
    Vengerovskiĭ AI; Ogorodova LM; Perevozchikova TV
    Eksp Klin Farmakol; 2004; 67(4):50-3. PubMed ID: 15500048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatoprotective properties of liproxol].
    Saratikov AS; Litvinenko IuA; Burkova VN; Vengerovskiĭ AI; Chuchalin VS
    Eksp Klin Farmakol; 2002; 65(2):31-3. PubMed ID: 12109289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacological correction of the hepatotoxic action of platidiam].
    Fomina TI; Vetoshkina TV; Dubskaia TIu
    Eksp Klin Farmakol; 1999; 62(1):62-4. PubMed ID: 10198772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of hepatoprotective agents in experimental chronic hepatitis].
    Saratikov AS; Vengerovskiĭ ; Baturina NO; Chuchalin VS
    Eksp Klin Farmakol; 1996; 59(1):24-6. PubMed ID: 8704626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of hepatoprotectors containing phospholipids on rats with experimental acute pancreatitis].
    Saratikov AS; Vengerovskiĭ AI; Mozzhelin ME; Sukhodolo IV
    Eksp Klin Farmakol; 2004; 67(4):35-7. PubMed ID: 15500043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enteric sorbents potentiate hepatoprotective effect of eplir in experimental toxic hepatitis].
    Vengerovskiĭ AI; Golovina EL; Burkova VN; Saratikov AS
    Eksp Klin Farmakol; 2001; 64(1):46-8. PubMed ID: 11544804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental antioxidant therapy in toxic liver damage from CCl4 and chloxyl].
    Vinogradova LF; Mirzoian ZhA; Kharlitskaia EV; Beketova TP
    Patol Fiziol Eksp Ter; 1989; (4):52-6. PubMed ID: 2556682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hepatoprotectors on lipid metabolism in CCl4-hepatitis].
    Vengerovskiĭ AI; Chuchalin VS; Paul's OV; Saratikov AS
    Biull Eksp Biol Med; 1987 Apr; 103(4):430-2. PubMed ID: 3567336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The correction with hepatic protectors of structural metabolic disorders in the liver in D-galactosamine poisoning].
    Saratikov AS; Vengerovskiĭ AI; Sedykh IM
    Farmakol Toksikol; 1990; 53(2):38-40. PubMed ID: 2369952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the effects of essentiale and the novel Russian hepatoprotective agent "phospholiv" in a model of acute hepatitis in rats].
    Ipatova OM; Torkhovskaia TI; Kniazhev VA; Karuzina II; Bachmanova GI; Guseva MK; Archakov AI
    Vopr Med Khim; 1998; 44(6):544-50. PubMed ID: 10599140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatoprotective effect of lipophen--a novel natural combined phospholipid preparation].
    Gordienko AD
    Eksp Klin Farmakol; 2001; 64(3):45-7. PubMed ID: 11558438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Essentiale as an immunomodulator in a toxic liver lesion].
    Konoplia EN; Prokopenko LG
    Eksp Klin Farmakol; 1992; 55(6):49-51. PubMed ID: 1305878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An experimental study of the hepatoprotective properties of phytoecdysteroids and nerobol in carbon tetrachloride-induced liver lesion].
    Syrov VN; Khushbaktova ZA; Nabiev AN
    Eksp Klin Farmakol; 1992; 55(3):61-5. PubMed ID: 1458171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of chenophalk on the liver function of intact animals and in experimental hepatitis].
    Alekseeva IN; Berezovskiĭ VA; Bryzgina TM; Dynnik OB; Pavlovich SI; Nosar' VI; Aleksiuk LI; Makogon NV; Gotsuliak IaN; Portnichenko AG
    Eksp Klin Farmakol; 1994; 57(1):35-8. PubMed ID: 8142861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New hepatoprotective agents of natural origin].
    Saratikov AS; Vengerovskiĭ AI
    Eksp Klin Farmakol; 1995; 58(1):8-11. PubMed ID: 7787707
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of phospholipid hepatoprotectors on apoptosis during experimental liver pathology induced by isoniazid and paracetamol.
    Udut VV; Vengerovsky AI; Dygai AM
    Bull Exp Biol Med; 2013 Mar; 154(5):614-7. PubMed ID: 23658881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of phospholipid hepatoprotectors on lipid peroxidation in liver and content of cytokines in the blood in experimental pathology caused by isoniazid].
    Udut VV; Vengerovskiĭ AI; Burkova VN; Vaizova OE; Korshunov DA
    Eksp Klin Gastroenterol; 2012; (6):47-52. PubMed ID: 23402191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of hepatoprotective agents containing phospholipids on cytochrome P-450-dependent antitoxic liver function during experimental toxic hepatitis].
    Saratikov AS; Vengerovskiĭ AI
    Biull Eksp Biol Med; 1999 Apr; 127(4):392-4. PubMed ID: 10367119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.